Respiratory Care Guidelines

Introduction to Nebulized Saline Solutions

Nebulized hypertonic saline solution is recommended by the American Academy of Pediatrics for mild to moderate bronchiolitis caused by VSR, with a concentration of 3% and frequency of 3-4 times a day, especially in settings where the average hospital stay exceeds 3 days 1
The American Academy of Pediatrics and the European Respiratory Society support the use of nebulized saline solutions as part of a comprehensive approach, including oxygen therapy and adequate hydration, with a strength of evidence based on clinical guidelines 1, 2, 3

The nebulization time for bronchodilators should be less than 10 minutes, and continued for approximately one minute after the solution starts to "bubble", using a high-performance nebulizer and a compressor with a flow rate of 6-8 L/min, as recommended by the American College of Chest Physicians 3
A mouthpiece should be used instead of a mask whenever possible, especially for adults, and if a mask is used, the patient should breathe with their mouth open, with daily cleaning of the nebulizer involving disassembling, washing with warm water and detergent, and drying carefully 3
Proper cleaning of nebulizer equipment is essential to prevent contamination, including cleaning after each use, replacing disposable parts every three months, and having the compressor serviced annually, as recommended by the European Respiratory Society and the American College of Chest Physicians 3

Isotonic (0.9%) saline is recommended as a first-line option, administered at 5 ml per treatment, up to every 6 hours as needed for symptom relief, using a standard jet nebulizer with an appropriate compressor (6-8 L/min flow rate), as recommended by the European Respiratory Society 3
Hypertonic saline solution (9 mg in 3 ml) is recommended twice a day for 15-30 consecutive days to improve symptoms and endoscopic outcomes, with pre-treatment with bronchodilators (e.g., salbutamol) to prevent bronchospasm, as recommended by the European Respiratory Society and the American College of Chest Physicians 4, 5, 6
The American Thoracic Society recommends administering nebulized hypertonic saline in a sequence of bronchodilator, followed by nebulized hypertonic saline, then airway clearance techniques, and finally nebulized antibiotics or inhaled steroids if prescribed, to prevent bronchospasm and optimize mucus clearance 7

Patient education should include proper technique and cleaning procedures to ensure safe and effective use, with patients being monitored for respiratory rate, work of breathing, and oxygen saturation during initial treatments, and assessed for clinical improvement in symptoms and mucus clearance, as recommended by the European Respiratory Society and the American College of Chest Physicians 5, 3
Common side effects of hypertonic saline include cough, throat irritation, and salty taste, with the recommendation to discontinue treatment if significant bronchospasm or adverse effects occur, based on clinical guidelines and patient safety considerations 7

Nebulized saline solution is useful as an adjunct in patients with chronic obstructive pulmonary disease (COPD) and lung cancer for symptom management, possibly by facilitating the elimination of sputum, although it does not significantly affect lung function as measured by forced expiratory volume in one second (FEV1), as suggested by the European Respiratory Society 8
Hypertonic saline is particularly beneficial for mucus clearance in patients with extensive bronchiectasis, and should be used with caution in asthmatic patients, always pre-treated with bronchodilators to prevent bronchospasm, as stated by the European Respiratory Society and supported by evidence 5, 6
For patients who don't respond to isotonic saline, consider adding chest physiotherapy techniques to enhance secretion clearance, or ensuring adequate systemic hydration to thin secretions, as an adjunct to standard antibiotic therapy for respiratory infections, as supported by the European Respiratory Society guidelines 8
Saline nebulizers can help loosen secretions and facilitate expectoration in respiratory infections, including walking pneumonia, by hydrating airway secretions, promoting mucus clearance, and potentially reducing cough severity, as noted by the European Respiratory Society and supported by evidence 3, 8